JBCHEPHARM Historical Income Statement

JBCHEPHARM

1,750 2.80 0.16%

Historical analysis of JB Chemicals income statement accounts such as Total Revenue of 36.2 B or Gross Profit of 9.8 B can show how well JB Chemicals Pharmaceuticals performed in making a profits. Evaluating JB Chemicals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of JB Chemicals's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining JB Chemicals Pharmac latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether JB Chemicals Pharmac is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

About JBCHEPHARM Income Statement Analysis

JB Chemicals Pharmac Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to JB Chemicals shareholders. The income statement also shows JBCHEPHARM investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

JB Chemicals Income Statement Chart

As of now, JB Chemicals' Other Operating Expenses is increasing as compared to previous years. The JB Chemicals' current Operating Income is estimated to increase to about 7.9 B, while Gross Profit is projected to decrease to under 9.8 B.

Total Revenue Gross Profit Other Operating Expenses Operating Income Extraordinary Items

Total Revenue

Total revenue comprises all receipts JB Chemicals Pharmac generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of JB Chemicals Pharmaceuticals minus its cost of goods sold. It is profit before JB Chemicals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of JB Chemicals Pharmac. It is also known as JB Chemicals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from JB Chemicals Pharmac operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of JB Chemicals Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from JB Chemicals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into JB Chemicals Pharmac current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

	2021	2022	2023	2024 (projected)
Gross Profit	15.6B	27.7B	15.3B	9.8B
Total Revenue	24.2B	31.5B	34.5B	36.2B

Gross Profit Total Revenue

JB Chemicals income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Research Development	Minority Interest	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.83	0.99	0.7	0.75	0.97	0.69	0.76	0.85	0.98	0.5	-0.29	0.62	0.74	0.42	0.91	0.57	0.78	-0.54	0.75	-0.74	-0.91	0.86	-0.75
Interest Expense	0.83		0.8	0.51	0.53	0.81	0.83	0.86	0.73	0.79	0.58	0.12	0.78	0.79	0.48	0.76	0.54	0.5	-0.62	0.56	-0.47	-0.94	0.84	-0.77
Total Revenue	0.99	0.8		0.76	0.73	0.98	0.72	0.78	0.82	0.99	0.54	-0.28	0.65	0.74	0.46	0.91	0.61	0.78	-0.59	0.78	-0.77	-0.89	0.86	-0.7
Gross Profit	0.7	0.51	0.76		0.19	0.71	0.47	0.52	0.26	0.77	0.86	-0.27	0.42	0.37	0.82	0.46	0.9	0.71	-0.47	0.57	-0.42	-0.62	0.74	-0.11
Other Operating Expenses	0.75	0.53	0.73	0.19		0.77	0.57	0.62	0.95	0.71	-0.14	-0.19	0.52	0.75	-0.25	0.92	-0.09	0.57	-0.34	0.74	-0.87	-0.57	0.51	-0.78
Operating Income	0.97	0.81	0.98	0.71	0.77		0.77	0.82	0.84	0.97	0.49	-0.22	0.71	0.8	0.39	0.92	0.54	0.73	-0.55	0.83	-0.81	-0.88	0.84	-0.73
Ebit	0.69	0.83	0.72	0.47	0.57	0.77		1.0	0.65	0.68	0.51	0.45	0.99	0.96	0.29	0.69	0.37	0.45	-0.42	0.65	-0.63	-0.68	0.64	-0.58
Ebitda	0.76	0.86	0.78	0.52	0.62	0.82	1.0		0.7	0.74	0.52	0.37	0.98	0.96	0.32	0.74	0.41	0.51	-0.45	0.69	-0.66	-0.74	0.69	-0.63
Cost Of Revenue	0.85	0.73	0.82	0.26	0.95	0.84	0.65	0.7		0.79	0.03	-0.17	0.59	0.79	-0.08	0.95	0.07	0.58	-0.45	0.73	-0.8	-0.76	0.67	-0.89
Total Operating Expenses	0.98	0.79	0.99	0.77	0.71	0.97	0.68	0.74	0.79		0.55	-0.32	0.61	0.7	0.49	0.91	0.62	0.79	-0.62	0.76	-0.75	-0.89	0.86	-0.69
Income Before Tax	0.5	0.58	0.54	0.86	-0.14	0.49	0.51	0.52	0.03	0.55		0.08	0.49	0.31	0.95	0.2	0.96	0.43	-0.44	0.28	-0.07	-0.57	0.63	-0.02
Total Other Income Expense Net	-0.29	0.12	-0.28	-0.27	-0.19	-0.22	0.45	0.37	-0.17	-0.32	0.08		0.53	0.34	-0.12	-0.23	-0.2	-0.31	0.14	-0.16	0.16	0.21	-0.21	0.14
Net Income	0.62	0.78	0.65	0.42	0.52	0.71	0.99	0.98	0.59	0.61	0.49	0.53		0.94	0.26	0.63	0.33	0.4	-0.39	0.61	-0.59	-0.61	0.58	-0.53
Income Tax Expense	0.74	0.79	0.74	0.37	0.75	0.8	0.96	0.96	0.79	0.7	0.31	0.34	0.94		0.09	0.8	0.2	0.48	-0.35	0.75	-0.77	-0.67	0.61	-0.69
Selling General Administrative	0.42	0.48	0.46	0.82	-0.25	0.39	0.29	0.32	-0.08	0.49	0.95	-0.12	0.26	0.09		0.11	0.97	0.36	-0.48	0.1	0.05	-0.52	0.54	0.01
Selling And Marketing Expenses	0.91	0.76	0.91	0.46	0.92	0.92	0.69	0.74	0.95	0.91	0.2	-0.23	0.63	0.8	0.11		0.25	0.67	-0.58	0.8	-0.86	-0.83	0.76	-0.85
Net Income From Continuing Ops	0.57	0.54	0.61	0.9	-0.09	0.54	0.37	0.41	0.07	0.62	0.96	-0.2	0.33	0.2	0.97	0.25		0.5	-0.46	0.28	-0.11	-0.61	0.65	-0.08
Research Development	0.78	0.5	0.78	0.71	0.57	0.73	0.45	0.51	0.58	0.79	0.43	-0.31	0.4	0.48	0.36	0.67	0.5		-0.35	0.64	-0.66	-0.61	0.67	-0.36
Minority Interest	-0.54	-0.62	-0.59	-0.47	-0.34	-0.55	-0.42	-0.45	-0.45	-0.62	-0.44	0.14	-0.39	-0.35	-0.48	-0.58	-0.46	-0.35		-0.3	0.3	0.65	-0.64	0.47
Tax Provision	0.75	0.56	0.78	0.57	0.74	0.83	0.65	0.69	0.73	0.76	0.28	-0.16	0.61	0.75	0.1	0.8	0.28	0.64	-0.3		-0.87	-0.65	0.77	-0.47
Interest Income	-0.74	-0.47	-0.77	-0.42	-0.87	-0.81	-0.63	-0.66	-0.8	-0.75	-0.07	0.16	-0.59	-0.77	0.05	-0.86	-0.11	-0.66	0.3	-0.87		0.55	-0.54	0.6
Net Interest Income	-0.91	-0.94	-0.89	-0.62	-0.57	-0.88	-0.68	-0.74	-0.76	-0.89	-0.57	0.21	-0.61	-0.67	-0.52	-0.83	-0.61	-0.61	0.65	-0.65	0.55		-0.92	0.78
Reconciled Depreciation	0.86	0.84	0.86	0.74	0.51	0.84	0.64	0.69	0.67	0.86	0.63	-0.21	0.58	0.61	0.54	0.76	0.65	0.67	-0.64	0.77	-0.54	-0.92		-0.54
Extraordinary Items	-0.75	-0.77	-0.7	-0.11	-0.78	-0.73	-0.58	-0.63	-0.89	-0.69	-0.02	0.14	-0.53	-0.69	0.01	-0.85	-0.08	-0.36	0.47	-0.47	0.6	0.78	-0.54

Click cells to compare fundamentals

JB Chemicals Account Relationship Matchups

JB Chemicals income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	663.2M	686.7M	726.6M	1.1B	1.4B	1.5B
Interest Expense	29.2M	69.4M	47.9M	360.5M	443.3M	465.5M
Total Revenue	17.4B	20.1B	24.2B	31.5B	34.5B	36.2B
Gross Profit	10.9B	12.9B	15.6B	27.7B	15.3B	9.8B
Other Operating Expenses	14.2B	15.2B	19.5B	3.8B	26.9B	28.3B
Operating Income	3.2B	4.9B	4.7B	5.9B	7.5B	7.9B
Ebit	3.5B	6.0B	5.1B	5.9B	8.0B	8.3B
Ebitda	4.2B	6.7B	5.8B	7.0B	9.3B	9.8B
Cost Of Revenue	6.5B	7.2B	8.6B	3.8B	19.2B	20.2B
Total Operating Expenses	7.7B	8.0B	10.9B	14.0B	14.8B	15.5B
Income Before Tax	3.5B	6.0B	5.0B	27.7B	7.5B	4.4B
Total Other Income Expense Net	309.3M	1.1B	310.1M	(365.6M)	(26.5M)	(25.2M)
Net Income	2.7B	4.5B	3.9B	4.1B	5.5B	5.8B
Income Tax Expense	765.0M	1.5B	1.2B	893.1M	2.0B	2.1B
Selling General Administrative	43.3M	78.8M	579.9M	5.5B	337.0M	600.0M
Selling And Marketing Expenses	1.7B	1.8B	2.6B	1.8B	3.8B	4.0B
Net Income From Continuing Ops	2.7B	4.5B	3.9B	26.8B	5.5B	5.2B
Research Development	193.9M	235.3M	291.1M	319.3M	356.7M	270.5M
Net Income Applicable To Common Shares	2.7B	4.5B	3.9B	4.1B	4.7B	2.6B
Minority Interest	28.0M	25.0M	37.1M	(6.8M)	(1.7M)	0.0
Tax Provision	782.0M	1.5B	1.2B	893.1M	2.0B	1.1B
Interest Income	333.2M	72.4M	51.2M	360.5M	44.3M	42.1M
Net Interest Income	(4.1M)	(72.4M)	(51.2M)	(360.5M)	(443.3M)	(421.1M)
Reconciled Depreciation	663.2M	686.7M	726.6M	1.1B	1.4B	900.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in JBCHEPHARM Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

JBCHEPHARM Historical Income Statement

About JBCHEPHARM Income Statement Analysis

JB Chemicals Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

JB Chemicals income statement Correlations

JB Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

JB Chemicals income statement Accounts

Also Currently Popular

Other Information on Investing in JBCHEPHARM Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Ebit
Total Revenue	+ 0.99	Depreciation And Amortization
Total Operating Expenses	+ 0.99	Total Revenue
Net Income	+ 0.99	Ebit
Total Operating Expenses	+ 0.98	Depreciation And Amortization
Operating Income	+ 0.98	Total Revenue

Net Interest Income	- 0.94	Interest Expense
Reconciled Depreciation	- 0.92	Net Interest Income
Net Interest Income	- 0.91	Depreciation And Amortization
Net Interest Income	- 0.89	Total Operating Expenses
Extraordinary Items	- 0.89	Cost Of Revenue
Net Interest Income	- 0.89	Total Revenue